The Claim

Liraglutide administered once daily is associated with greater improvements in glycaemic control and better tolerability compared to exenatide administered twice daily in adults with type 2 diabetes, with potential clinical advantages when weight loss and hypoglycaemia risk are key concerns.

Source: Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
20score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Correlation
1 study reviewed
In plain English

In adults with type 2 diabetes, once-daily liraglutide leads to better blood sugar control and fewer side effects than twice-daily exenatide, particularly when weight loss and low risk of low blood sugar are important.

See the scientific wording

Liraglutide administered once daily is associated with greater improvements in glycaemic control compared to exenatide administered twice daily in adults with type 2 diabetes, and is generally better tolerated, suggesting potential clinical advantages when weight loss and hypoglycaemia risk are key concerns.

Why this might work

Liraglutide stays active in the body longer than exenatide, so it keeps stimulating insulin release from the pancreas and blocking glucagon release, which lowers blood sugar more steadily. It also irritates the stomach and intestines less, so people experience fewer nausea and vomiting episodes.

Supported mechanismbased on 1 study

What the research says

1 study

  1. Study: Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).

    In a study comparing two diabetes medicines, the once-daily shot (liraglutide) lowered blood sugar better and caused fewer side effects than the twice-daily shot (exenatide), making it a better choice for people trying to lose weight or avoid low blood sugar.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.